EULAV Asset Management’s Kite Pharma, Inc. KITE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q3
Sell
-81,000
Closed -$8.4M 321
2017
Q2
$8.4M Sell
81,000
-5,000
-6% -$518K 0.41% 79
2017
Q1
$6.75M Buy
+86,000
New +$6.75M 0.34% 104